Inspiratory Muscle and Peripheral Muscle Training in Chronic Heart Failure
2 other identifiers
interventional
30
1 country
1
Brief Summary
Heart failure is a clinical syndrome that is the common end of several cardiac diseases with symptoms such as muscle fatigue, dyspnea and reduction of quality of life. To improve respiratory and general functional capacity of these patients, there are strategies that can be used such as inspiratory muscle training and peripheral muscle training (dynamic resistance training).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 29, 2014
CompletedFirst Posted
Study publicly available on registry
October 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedDecember 7, 2015
December 1, 2015
3 years
September 29, 2014
December 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in respiratory muscle strength (in centimeters of water)
Inspiratory and expiratory muscle strength was assessed by using a pressure transducer (MVD-300 Microhard System, GlobalMed, Porto Alegre, Brazil).
Before and after 8-weeks
Secondary Outcomes (1)
walking distance
Before and after 8-weeks
Other Outcomes (8)
Change in pulmonary function
Before and after 8-weeks
Change in functional capacity
Before and after 8-weeks
Inflammation in the upper airway by cytokines in blood
Before and after 8-weeks
- +5 more other outcomes
Study Arms (3)
Control group
OTHERpatients awaiting for evaluation to cardiac rehabilitation or transplantation
moderate-intensity group
EXPERIMENTALPatients will be submitted to a 8-weeks training program, with inspiratory muscle trained at 30% of the maximal inspiratory pressure (30 minutes/session/7 days/week) and peripheral muscle trained with upper and lower exercises (50% of the 1-maximum repetition test).
low-intensity group
ACTIVE COMPARATORPatients will be submited to a 8 weeks training program, with inspiratory muscle trained at 15% of the maximal inspiratory pressure (30 minutes/session/7 days/week) and peripheral muscle trained with exercises of upper limbs and lower limbs (0,5 Kg each).
Interventions
No intervention during the 8-weeks period of the study because of awaiting evaluation for cardiac rehabilitation or transplantation
Patients will be submitted to a 8-weeks training program with inspiratory muscle trained at 30% of the maximal inspiratory pressure (30 minutes/session/7 days/week) + peripheral muscle trained with exercises of upper limbs and lower limbs (50% 1 RM, increased every 2-weeks).
Patients will be submited to a 8 weeks training program, with inspiratory muscle trained at 15% of the maximal inspiratory pressure (30 minutes/session/7 days/week) + peripheral muscle trained with exercises of upper limbs and lower limbs (0,5 kg each)
Eligibility Criteria
You may qualify if:
- chronic heart failure (functional class from NYHA II and III),
- left ventricle ejection fraction bellow or equal 40%.
You may not qualify if:
- uncontrolled arrhythmia
- pulmonary edema or pulmonary congestion in the last 30 days
- peripheral oxygen saturation bellow 92% in resting condition
- respiratory infection in the previous 30 days to the enrollment into the study
- cognitive, neurological or orthopedic limitations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Naomi Kondo Nakagawalead
- Fundação de Amparo à Pesquisa do Estado de São Paulocollaborator
- Instituto Dante Pazzanese de Cardiologiacollaborator
Study Sites (1)
Instituto Dante Pazzanese de Cardiologia
São Paulo, São Paulo, 04012-909, Brazil
Study Officials
- PRINCIPAL INVESTIGATOR
Naomi K Nakagawa, PhD
USP
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor of Medical School of Sao Paulo University
Study Record Dates
First Submitted
September 29, 2014
First Posted
October 13, 2014
Study Start
October 1, 2012
Primary Completion
October 1, 2015
Study Completion
December 1, 2015
Last Updated
December 7, 2015
Record last verified: 2015-12